12 September 2012 -- The BioIndustry Association (BIA) welcomes today's appointment by the Technology Strategy Board of Dr John Brown as Chairman of the Cell Therapy Catapult centre. Dr Brown is a member of the BIA Board.
Steve Bates, BIA Chief Executive Officer said:
"John brings excellent skills and a wealth of experience from the biotechnology sector to the role. He will ensure the Catapult helps make the UK a global leader in cell therapy where science is translated into potential treatments for patients.
"John's presence on our Board and as Chair of the Catapult will make sure that strong links are developed and maintained between the two organisations."
For further information, please contact Robert Winder, Head of Communications, email@example.com, 020 7630 2191; mobile 07825 942 934.
Keith Thompson, Chief Executive Officer of the Cell Therapy Catapult will give a keynote presentation about the vision and plans for the Cell Therapy Catapult at the BIA UK Bioscience Forum on 4 October. http://www.ukbioscienceforum.org/
Founded over 20 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives. For further information, please go to www.bioindustry.org